Opportunities and Obstacles Associated With Sequential Immune Reconstitution Therapy for Multiple Sclerosis: A Case Report.

Garbo, Riccardo; Cutuli, Daniela; Lorenzut, Simone; Gigli, Gian Luigi; Bagatto, Daniele; Valente, Mariarosaria

Garbo, Riccardo; Cutuli, Daniela; Lorenzut, Simone; Gigli, Gian Luigi; Bagatto, Daniele; Valente, Mariarosaria.

Afiliação

Garbo R; Clinical Neurology Unit, Department of Neurosciences, Santa Maria della Misericordia University Hospital, Udine, Italy.
Cutuli D; Neurology Unit, Department of Neurosciences, Santa Maria della Misericordia University Hospital, Udine, Italy.
Lorenzut S; Neurology Unit, Department of Neurosciences, Santa Maria della Misericordia University Hospital, Udine, Italy.
Gigli GL; Clinical Neurology Unit, Department of Neurosciences, Santa Maria della Misericordia University Hospital, Udine, Italy.
Bagatto D; Department of Medical Area (DAME), University of Udine, Udine, Italy.
Valente M; Neuroradiology Unit, Department of Diagnostic Imaging, Santa Maria della Misericordia University Hospital, Udine, Italy.

Front Neurol ; 12: 664596, 2021.

Article em En | MEDLINE | ID: mdl-34956035

Palavras-chave

alemtuzumab; case report; cladribine; immune reconstitution therapy; multiple sclerosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google